154 related articles for article (PubMed ID: 10705392)
21. In vitro and in vivo expression of somatostatin receptors in intermediate and malignant soft tissue tumors.
Florio T; Montella L; Corsaro A; De Chiara A; Apice G; Fazioli F; Lastoria S; Schettini G; Palmieri G
Anticancer Res; 2003; 23(3B):2465-71. PubMed ID: 12894529
[TBL] [Abstract][Full Text] [Related]
22. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
[TBL] [Abstract][Full Text] [Related]
23. Expression of estrogen receptors alpha and beta in soft tissue sarcomas: Immunohistochemical and molecular analysis.
Li XQ; Hisaoka M; Hashimoto H
Pathol Int; 2003 Oct; 53(10):671-9. PubMed ID: 14516317
[TBL] [Abstract][Full Text] [Related]
24. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.
Nakayama R; Nemoto T; Takahashi H; Ohta T; Kawai A; Seki K; Yoshida T; Toyama Y; Ichikawa H; Hasegawa T
Mod Pathol; 2007 Jul; 20(7):749-59. PubMed ID: 17464315
[TBL] [Abstract][Full Text] [Related]
25. Anti-CD10 (56C6) expression in soft tissue sarcomas.
Deniz K; Çoban G; Okten T
Pathol Res Pract; 2012 May; 208(5):281-5. PubMed ID: 22464152
[TBL] [Abstract][Full Text] [Related]
26. [Pathology of the most common malignant soft tissue tumors].
Donhuijsen K; Leder LD
Radiologe; 1983 Nov; 23(11):491-501. PubMed ID: 6316410
[TBL] [Abstract][Full Text] [Related]
27. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
28. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
[TBL] [Abstract][Full Text] [Related]
29. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
[TBL] [Abstract][Full Text] [Related]
30. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
31. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma.
Fletcher CD
Am J Surg Pathol; 1992 Mar; 16(3):213-28. PubMed ID: 1317996
[TBL] [Abstract][Full Text] [Related]
32. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
[TBL] [Abstract][Full Text] [Related]
33. Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
Tanriverdi O; Yildiz A
J Oncol Pharm Pract; 2022 Apr; 28(3):635-645. PubMed ID: 35043739
[TBL] [Abstract][Full Text] [Related]
34. The problem of the poorly differentiated sarcoma.
Ross J; Hendrickson MR; Kempson RL
Semin Oncol; 1982 Dec; 9(4):467-83. PubMed ID: 6302907
[No Abstract] [Full Text] [Related]
35. Grading in soft tissue tumors: principles and problems.
Oliveira AM; Nascimento AG
Skeletal Radiol; 2001 Oct; 30(10):543-59. PubMed ID: 11685477
[TBL] [Abstract][Full Text] [Related]
36. Telomerase activity in cell lines of pediatric soft tissue sarcomas.
Kleideiter E; Schwab M; Friedrich U; Koscielniak E; Schafer BW; Klotz U
Pediatr Res; 2003 Nov; 54(5):718-23. PubMed ID: 12904596
[TBL] [Abstract][Full Text] [Related]
37. [Importance of specialized centers in diagnosis and treatment of extremity-soft tissue sarcomas. Review of 603 cases].
Lehnhardt M; Daigeler A; Homann HH; Hauser J; Langer S; Steinsträsser L; Soimaru C; Puls A; Steinau HU
Chirurg; 2009 Apr; 80(4):341-7. PubMed ID: 18523742
[TBL] [Abstract][Full Text] [Related]
38. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
39. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions.
Hiyama T; Yokozaki H; Kitadai Y; Tahara E; Tahara H; Ide T; Haruma K; Yasui W; Kajiyama G; Tahara E
Jpn J Cancer Res; 1998 Nov; 89(11):1187-94. PubMed ID: 9914788
[TBL] [Abstract][Full Text] [Related]
40. Leiomyosarcoma and malignant fibrous histiocytoma share similar allelic imbalance pattern at 9p.
Sabah M; Cummins R; Leader M; Kay E
Virchows Arch; 2005 Mar; 446(3):251-8. PubMed ID: 15731925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
